Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3154 participants.

Also called NCT02898610

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 3,154 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02898610
Other papers using this trial's data
  • Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis Stroke, 2026-10 DOI, PubMed 42619594
  • Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial European stroke journal, 2026-07-06 DOI, PubMed 42418305, PMC13344104 In the PMC Open Access subset under CC BY-NC.
  • Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial International journal of stroke : official journal of the International Stroke Society, 2026-08 DOI, PubMed 41328787
  • Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial Lancet (London, England), 2024-07-13 DOI, PubMed 38857611
  • Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial European stroke journal, 2026-04-06 DOI, PubMed 42032972, PMC13109098 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Canada, Czechia, Denmark, Estonia, Germany, Ireland, Lithuania, Netherlands, Poland, Portugal, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02898610. Randomized; no masking; primary purpose prevention. Start 2016-12-12 (actual); primary completion 2024-01-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
Acronym
CONVINCE
Condition
Ischemic Attack, Transient
Condition
Stroke
Intervention (Drug)
Colchicine
Lead sponsor
University College Dublin (class: other)
Collaborator
Health Research Board, Ireland (class: other)
Collaborator
Irish Heart Foundation (class: other)
Collaborator
University of Limerick (class: other)
Collaborator
University of Edinburgh (class: other)
Collaborator
National University of Ireland, Galway, Ireland (class: other)
Collaborator
Universitat de Lleida (class: other)
Collaborator
Universitaire Ziekenhuizen KU Leuven (class: other)

Record details

Record id
cardio:ct-nct02898610
Content hash
4f3b6a111ad62d89057fd2322c3688751c95c92187cc649efe45a1243c19ee12